BTG INTERNATIONAL INC.

VORAXAZE

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

BTG INTERNATIONAL INC.

Voraxaze HCPCS:

NOC Glucarpidase

HCPCS Code Descriptor:

NOC Glucarpidase

Category:

NOC Code

Voraxaze NDCs:

50633-0210-11

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Not Found

Route of Administration:

Intravenous

Voraxaze CPT Codes:

Potential CPT administration codes for Voraxaze can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Voraxaze:

VORAXAZE is a Oncology drug manufactured by BTG INTERNATIONAL INC. and administered via the Intravenous route of administration. The NOC Code: NOC Glucarpidase is aligned to the drug VORAXAZE.

ACCESS PRICING AND MORE BY REGISTERING

NOC Glucarpidase Added Date:

NA

NOC Glucarpidase Effective Date:

NA

NOC Glucarpidase Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Voraxaze billing and coding information.
Our team did not identify a source for Voraxaze patient assistance information. Please reach out to our team if you feel that this is a mistake.
VORAXAZE prescribing information can be found at the link below:
Information regarding VORAXAZE’s side effects can be found at MedlinePlus